Insulin, Pharmacy Benefit Managers
High insulin prices spur a federal lawsuit against three pharmacy benefit managers
The federal government is suing some big pharmacy benefit managers over a system of drug rebates that regulators say has made the price of insulin soar for diabetic patients. Three companies that process about 80% of prescriptions in the United States — Caremark,
Pharmacy benefit managers respond to FTC's lawsuit over insulin drug prices
CNBC's Eamon Javers joins 'The Exchange' to report the latest on the FTC's lawsuit against drug middlemen for allegedly inflating insulin prices.
Opinion
Commentary: Pharmacy benefit managers need tougher regulations
A group of Fortune 15 corporations have amassed enormous power as controversial middlemen between insurers, patients, drug makers and pharmacies.
Explainer: Why are US pharmacy benefit managers under fire?
The U.S. Federal Trade Commission said on Friday it was suing the country's three largest pharmacy benefit managers, accusing them of abusing their power and rigging the pharmaceutical supply chain to artificially inflate the cost of insulin.
New Idaho law to regulate pharmacy benefit managers. Will it reduce prescription drug costs?
In January, a new Idaho law will take effect requiring reform of business practices by pharmacy middlemen — in search of tamping down prescription drug costs. The new law targets pharmacy benefit managers,
Pharmacy benefit managers, version 2.0 (post J&J lawsuit)
2025 and 2026, they're right around the corner, and many employers are making changes now for 2025 or are anticipating changes for 2026, given a lot of the media attention around the lawsuits, prescription prices, the conversation around being a fiduciary, etc. It's really a pivotal time for pharmacy benefits.
FTC sues major pharmacy benefit managers over insulin prices
The agency brought action against Caremark, Express Scripts and Optum Rx on Friday, arguing their “anticompetitive and unfair” rebating practices “artificially inflated” the list price of life-saving insulin drugs.
Express Scripts sues FTC over a ‘biased’ report about pharmacy benefit managers
Express Scripts, one of the largest pharmacy benefit managers in the U.S., filed a lawsuit demanding that a recent FTC report on industry middlemen be vacated.
High insulin prices spur federal lawsuit against 3 pharmacy benefit managers
Three companies that process about 80% of prescriptions in the United States — Caremark, Express Scripts and OptumRx — have engaged in anticompetitive practices that spur price increases, the Federal Trade Commission alleged in a lawsuit filed Friday.
thelundreport3d
Health care giant sues to stop antitrust probe of pharmacy drug middlemen
The owner of one of the three largest pharmacy middlemen in the United States on Tuesday filed suit to quash an attempt by ...
JD Supra4d
Recent Legislative Developments Impacting Pharmacy Benefit Managers, Health Plans & More
As prescription drug costs remains a significant, and largely bipartisan, issue for state and federal legislators, we ...
Legislative panel backs emergency rule to boost pharmacy reimbursement
Rand told lawmakers that for about the past year, health insurance plans and pharmacy benefit managers have been reimbursing ...
Federal Trade Commission sues drug 'gatekeepers' over high insulin prices
The three price benefit managers jointly administer 80% of all prescriptions in the U.S., the FTC said in the lawsuit.
Boise State Public Radio1d
FTC sues insulin middlemen, saying they pocket billions while patients face high costs
The Federal Trade Commission said pharmacy benefit managers created a "perverse drug rebate system" that artificially ...